Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/3015% above fair value
$4.13−0.28 (-6.35%)
Close on Nov 13, 2026Market cap $100.05MP/E –Yield –
Exagen operating margin
Operating margin is operating income as a percentage of revenue.
Exagen's operating margin for the twelve months ending Sep 30, 2026 was -20.1%. For fiscal 2025 it was -21.1%, against -24.5% the year before. The highest annual figure on record is -15.0% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21.1% | +3.4 |
| FY2024 | Dec 31, 2024 | -24.5% | +19.0 |
| FY2023 | Dec 31, 2023 | -43.5% | +57.6 |
| FY2022 | Dec 31, 2022 | -101.1% | −51.2 |
| FY2021 | Dec 31, 2021 | -49.8% | −13.7 |
| FY2020 | Dec 31, 2020 | -36.2% | −13.2 |
| FY2019 | Dec 31, 2019 | -23.0% | −8.0 |
| FY2018 | Dec 31, 2018 | -15.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -23.9% | −6.0 |
| Q2 FY2026 | Jun 30, 2026 | -8.6% | +6.7 |
| Q1 FY2026 | Mar 31, 2026 | -19.7% | +2.0 |
| Q4 FY2025 | Dec 31, 2025 | -29.9% | −5.1 |
| Q3 FY2025 | Sep 30, 2025 | -18.0% | +19.3 |
| Q2 FY2025 | Jun 30, 2025 | -15.3% | +1.9 |
| Q1 FY2025 | Mar 31, 2025 | -21.7% | −0.9 |
| Q4 FY2024 | Dec 31, 2024 | -24.8% | +12.6 |
| Q3 FY2024 | Sep 30, 2024 | -37.3% | +0.5 |
| Q2 FY2024 | Jun 30, 2024 | -17.2% | +17.6 |
| Q1 FY2024 | Mar 31, 2024 | -20.8% | +47.8 |
| Q4 FY2023 | Dec 31, 2023 | -37.4% | +75.5 |
| Q3 FY2023 | Sep 30, 2023 | -37.8% | +15.3 |
| Q2 FY2023 | Jun 30, 2023 | -34.8% | +150.1 |
| Q1 FY2023 | Mar 31, 2023 | -68.6% | +24.5 |
| Q4 FY2022 | Dec 31, 2022 | -112.9% | −63.6 |
| Q3 FY2022 | Sep 30, 2022 | -53.1% | +0.0 |
| Q2 FY2022 | Jun 30, 2022 | -184.9% | −139.9 |
| Q1 FY2022 | Mar 31, 2022 | -93.1% | −40.5 |
| Q4 FY2021 | Dec 31, 2021 | -49.3% | −27.5 |
| Q3 FY2021 | Sep 30, 2021 | -53.1% | −18.0 |
| Q2 FY2021 | Jun 30, 2021 | -45.0% | −6.8 |
| Q1 FY2021 | Mar 31, 2021 | -52.6% | +1.9 |
| Q4 FY2020 | Dec 31, 2020 | -21.8% | +6.2 |
| Q3 FY2020 | Sep 30, 2020 | -35.1% | −14.5 |
| Q2 FY2020 | Jun 30, 2020 | -38.2% | −15.2 |
| Q1 FY2020 | Mar 31, 2020 | -54.5% | −34.2 |
| Q4 FY2019 | Dec 31, 2019 | -28.0% | −26.4 |
| Q3 FY2019 | Sep 30, 2019 | -20.7% | −6.9 |
| Q2 FY2019 | Jun 30, 2019 | -23.0% | – |
| Q1 FY2019 | Mar 31, 2019 | -20.2% | – |
| Q4 FY2018 | Dec 31, 2018 | -1.6% | – |
| Q3 FY2018 | Sep 30, 2018 | -13.8% | – |
See a number that looks wrong?